Ishares Genomics Immunology Etf Volatility

IDNA Etf  USD 24.63  0.02  0.08%   
iShares Genomics Imm holds Efficiency (Sharpe) Ratio of -0.0101, which attests that the entity had a -0.0101% return per unit of risk over the last 3 months. iShares Genomics Imm exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Genomics' Market Risk Adjusted Performance of (0.04), risk adjusted performance of (0.03), and Standard Deviation of 1.18 to validate the risk estimate we provide. Key indicators related to IShares Genomics' volatility include:
90 Days Market Risk
Chance Of Distress
90 Days Economic Sensitivity
IShares Genomics Etf volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of IShares daily returns, and it is calculated using variance and standard deviation. We also use IShares's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of IShares Genomics volatility.
  
Downward market volatility can be a perfect environment for investors who play the long game with IShares Genomics. They may decide to buy additional shares of IShares Genomics at lower prices to lower the average cost per share, thereby improving their portfolio's performance when markets normalize.

Moving together with IShares Etf

  0.61XLV Health Care SelectPairCorr
  0.67VHT Vanguard Health CarePairCorr
  0.94IBB iShares Biotechnology ETFPairCorr
  0.96XBI SPDR SP BiotechPairCorr
  0.63IYH iShares Healthcare ETFPairCorr
  0.67FHLC Fidelity MSCI HealthPairCorr
  0.85ARKG ARK Genomic Revolution Low VolatilityPairCorr

IShares Genomics Market Sensitivity And Downside Risk

IShares Genomics' beta coefficient measures the volatility of IShares etf compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents IShares etf's returns against your selected market. In other words, IShares Genomics's beta of 1.01 provides an investor with an approximation of how much risk IShares Genomics etf can potentially add to one of your existing portfolios. iShares Genomics Immunology exhibits very low volatility with skewness of -0.65 and kurtosis of 0.97. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IShares Genomics' etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IShares Genomics' etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze iShares Genomics Imm Demand Trend
Check current 90 days IShares Genomics correlation with market (Dow Jones Industrial)

IShares Beta

    
  1.01  
IShares standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  1.23  
It is essential to understand the difference between upside risk (as represented by IShares Genomics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of IShares Genomics' daily returns or price. Since the actual investment returns on holding a position in ishares etf tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in IShares Genomics.

iShares Genomics Imm Etf Volatility Analysis

Volatility refers to the frequency at which IShares Genomics etf price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with IShares Genomics' price changes. Investors will then calculate the volatility of IShares Genomics' etf to predict their future moves. A etf that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A etf with relatively stable price changes has low volatility. A highly volatile etf is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of IShares Genomics' volatility:

Historical Volatility

This type of etf volatility measures IShares Genomics' fluctuations based on previous trends. It's commonly used to predict IShares Genomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the etf.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for IShares Genomics' current market price. This means that the etf will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on IShares Genomics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. iShares Genomics Imm Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

IShares Genomics Projected Return Density Against Market

Given the investment horizon of 90 days the etf has the beta coefficient of 1.0101 . This usually indicates iShares Genomics Immunology market returns are sensitive to returns on the market. As the market goes up or down, IShares Genomics is expected to follow.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IShares Genomics or iShares sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IShares Genomics' price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IShares etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
IShares Genomics Immunology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Predicted Return Density   
       Returns  
IShares Genomics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how ishares etf's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an IShares Genomics Price Volatility?

Several factors can influence a etf's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

IShares Genomics Etf Risk Measures

Given the investment horizon of 90 days the coefficient of variation of IShares Genomics is -9884.26. The daily returns are distributed with a variance of 1.5 and standard deviation of 1.23. The mean deviation of iShares Genomics Immunology is currently at 0.91. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α
Alpha over Dow Jones
-0.18
β
Beta against Dow Jones1.01
σ
Overall volatility
1.23
Ir
Information ratio -0.15

IShares Genomics Etf Return Volatility

IShares Genomics historical daily return volatility represents how much of IShares Genomics etf's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The ETF inherits 1.2256% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7777% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About IShares Genomics Volatility

Volatility is a rate at which the price of IShares Genomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of IShares Genomics may increase or decrease. In other words, similar to IShares's beta indicator, it measures the risk of IShares Genomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of IShares Genomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
The fund generally will invest at least 80 percent of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Genomics Immunology is traded on NYSEARCA Exchange in the United States.
IShares Genomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on IShares Etf over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much IShares Genomics' price varies over time.

3 ways to utilize IShares Genomics' volatility to invest better

Higher IShares Genomics' etf volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of iShares Genomics Imm etf is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. iShares Genomics Imm etf volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of iShares Genomics Imm investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in IShares Genomics' etf can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of IShares Genomics' etf relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

IShares Genomics Investment Opportunity

iShares Genomics Immunology has a volatility of 1.23 and is 1.58 times more volatile than Dow Jones Industrial. 10 percent of all equities and portfolios are less risky than IShares Genomics. You can use iShares Genomics Immunology to protect your portfolios against small market fluctuations. The etf experiences a normal downward trend and little activity. Check odds of IShares Genomics to be traded at $24.38 in 90 days.

Poor diversification

The correlation between iShares Genomics Immunology and DJI is 0.65 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and DJI in the same portfolio, assuming nothing else is changed.

IShares Genomics Additional Risk Indicators

The analysis of IShares Genomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in IShares Genomics' investment and either accepting that risk or mitigating it. Along with some common measures of IShares Genomics etf's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential etfs, we recommend comparing similar etfs with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

IShares Genomics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against IShares Genomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. IShares Genomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, IShares Genomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to iShares Genomics Immunology.
When determining whether iShares Genomics Imm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Genomics Immunology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Genomics Immunology Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.